Roundup Cancer Settlement Being Driven by Big Victories in Lawsuits

roundup weedkiller

News has filtered out that Bayer AG, the company that purchased the manufacturer of Roundup Weed Killer, will be settling with many of the victims who’ve accused the product of causing their Roundup cancer. The rumored amount of the settlement is $10 billion, a huge amount being driven by three guilty verdicts and enormous damages amounts that have already been awarded by juries.

The three Roundup cancer lawsuits that have been heard so far have resulted in headline-making awards being given to victims. A San Fransisco jury ordered Monsanto to pay school groundskeeper Dewayne “Lee” Johnson $289 million in damages following his diagnosis with non-Hodgkin’s lymphoma. That verdict was later reduced to $78 million. Another San Francisco jury heard Edwin Hardeman’s case in a federal court and ordered the company to pay the victim $80 million. And most recently, a couple was awarded $2 billion-plus another $55 million in damages. Those damages were also reduced, but the jury reached its verdict after less than two full days, ruling that the company had “engaged in conduct with malice, oppression or fraud committed by one or more officers, directors or managing agents of Monsanto.”

Roundup Cancer Trials Have Revealed Wrongful Actions

The evidence that has been presented against Monsanto in the Roundup cancer lawsuits have been particularly damning of their decision-making process and their demonstrated lack of care for those exposed to their product. Among the points that have been raised are:

  • The company failed to conduct epidemiology studies of their glyphosate products to determine whether they posed a cancer risk for users.
  • The company knew that Roundup’s surfactants enhanced the toxicity of the glyphosate.
  • The company ran secret public relations campaigns costing millions of dollars to discredit scientists that had found their products dangerous. The expenses included ghostwritten studies and articles.
  • The company developed alliances within the Environmental Protection Agency that they leveraged to back up their own claims of their glyphosate products’ safety.
  • The company solicited help from EPA officials to delay a planned review of glyphosate toxicity by the US Agency for Toxic Substances and Disease Registry.
  • Monsanto required their workers to wear extensive protective gear when working with their glyphosate products but provided consumers with no similar warnings about taking those precautions.

Author: Terri Oppenheimer

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor, and proofreader. She graduated from the College of William and Mary with a degree in English. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.